Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000899243-21-026766

10% owner bought 157,895 shares at $19.00 ($3,000,005)

  • 10% owner acquired 8,455,912 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Conversion +6,515,869 6,799,115 D: show line 1 in the form
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Conversion +1,940,043 1,940,043 I: show line 2 in the form
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Purchase +157,895 $19.00 $3,000,005 2,097,938 I: show line 3 in the form
Open-market purchases · 157,895 sh · avg $19.00 · $3,000,005

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Conversion · Series A convertible preferred stock −20,004,280 0 D: show line 4 in the form
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Conversion · Series B convertible preferred stock −3,000,000 0 D: show line 5 in the form
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Conversion · Series B convertible preferred stock −4,150,000 0 I: show line 6 in the form
Versant Venture Capital VI, L.P. 10% owner 2021-06-28 Conversion · Series C convertible preferred stock −2,699,328 0 I: show line 7 in the form
Loading xslF345X03/doc4.xml…